Fairmount Funds Management LLC Insider Trades & Stock Holdings

Spyre Therapeutics, Inc. · Latest filing Jun 23, 2026

Fairmount Funds Management LLC at Spyre Therapeutics, Inc. has 2 Form 4 trades on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($399.66M), net -$399.66M. Latest filing: disposed of 4.68M shares of $SYRE on Jun 23, 2026 at $85.31.

Trades on file

2

Open-market bought

$0

Open-market sold

$399.66M

Net open-market

-$399.66M

Latest filing

Jun 23, 2026

All insider trades by Fairmount Funds Management LLC

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$SYRE	Sell (Open-market sale)	4.68M	$85.31	$399.66M			-8.5%	+3.0%				Read
Jun 23, 2026	$SYRE	Buy (Conversion)	666.68K	—	—			-8.5%	+3.0%				Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Fairmount Funds Management LLC traded

• $SYRE

Frequently asked questions

Has Fairmount Funds Management LLC been buying or selling stock?

Fairmount Funds Management LLC has 0 open-market purchases and 1 open-market sale on file, net -$399.66M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Fairmount Funds Management LLC's latest insider trade?

disposed of 4.68M shares of $SYRE on Jun 23, 2026 at $85.31.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.